The trademark XERORINSE was filed by Actavis Group PTC ehf, a corporation established under the laws of the Republic of Iceland (the "Applicant"). The application was published for oppositions on May 12, 2013, and received one opposition filed on August 8, 2013 by DENTAID, S.L.(SOCIEDAD UNIPERSONAL) on Likelihood of confusion. the opponent was represented by PONTI & PARTNERS, S.L.P and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 8, 2013
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Absolute errors of the trademark registration was recorded on February 3, 2016. Requests for conversion of an EUTM application into a national trade mark application of the trademark registration was recorded on February 24, 2016.
The Appeal with reference B R2193/2014-5 was Opposition allowed according to Rule 94 CTMIR with decision issued on April 22, 2015 by the EUIPO. The Opposition with reference B 002225939 was refused according to Article 8(1)(b) CTMR with decision issued on June 24, 2014 by the EUIPO.